# Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)

> **NCT01996683** · NA · UNKNOWN · sponsor: **Ain Shams University** · enrollment: 50 (estimated)

## Conditions studied

- Beta-thalassemia
- Serum Ferritin
- Iron Chelation Therapy

## Interventions

- **DRUG:** desferal, ferriprox, blood transfusion

## Key facts

- **NCT ID:** NCT01996683
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2015-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01996683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01996683, "Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01996683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*